Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Igor Proscurshim"'
Autor:
Rodrigo O. Perez, Guilherme P. São Julião, Igor Proscurshim, Charles Sabbagh, Esteban Grzona, Patricio B. Lynn, Joaqim Gama-Rodrigues
Publikováno v:
Journal of Coloproctology, Vol 34, Iss 1, Pp 41-47 (2014)
The treatment of rectal cancer has evolved significantly over the last 100 years. Standardiza- tion of total mesorectal excision and the development of techniques for sphincter preserva- tion have resulted in significant improvements in the managemen
Externí odkaz:
https://doaj.org/article/e2a713807a604878aa1b6bca0870a79a
Autor:
Rodrigo Oliva Perez, Igor Proscurshim, Guilherme Pagin São Julião, Mauro Picolo, Joaquim Gama-Rodrigues, Angelita Habr-Gama
Publikováno v:
ABCD: Arquivos Brasileiros de Cirurgia Digestiva, Vol 21, Iss 1, Pp 12-15 (2008)
RACIONAL: O câncer colorretal é causa de morte de cerca de 500.000 pessoas-ano em todo o mundo, sendo a terceira principal causa de óbito por neoplasia. A mortalidade destes pacientes está diretamente relacionada com o estádio em que é feito o
Externí odkaz:
https://doaj.org/article/5db2c4f01d13499986700ab001744375
Autor:
Igor Proscurshim, Rodrigo Oliva Perez, Rosa Maria Nascimento Santos, Edson Luiz Zaparoli, Desidério Roberto Kiss, Angelita Habr-Gam
Publikováno v:
ABCD: Arquivos Brasileiros de Cirurgia Digestiva, Vol 20, Iss 1, Pp 12-16 (2007)
RACIONAL: Um dos mecanismos genéticos presentes em aproximadamente 80% dos pacientes com síndrome hereditária não-polipóide do câncer colorretal (HNPCC) são os defeitos nos genes reparadores de DNA, como o MSH2, MSH6 e MLH1, onde os tumores si
Externí odkaz:
https://doaj.org/article/486aa850214343ff88eabb60471ec96a
Autor:
Sanjay R Mohan, Cristiana Costa Chase, Jesus G Berdeja, Lionel Karlin, Karim Belhadj, Aurore Perrot, Philippe Moreau, Cyrille Touzeau, Thomas Chalopin, Alexander M Lesokhin, Carol Ann Huff, David H. Vesole, Joshua Richter, Jeffrey V. Matous, Igor Proscurshim, Eileen Wolff, Girish Gudi, Andrew Garton, Vinu Menon, Sunitha Gn, Yacine Salhi, Eric J. Feldman, Mohamad Mohty
Publikováno v:
Blood. 140:7264-7266
Autor:
Hanlon Sia, Peter T. Tan, Joshua Richter, Phoebe Joy Ho, Tara Cochrane, Hang Quach, Binod Dhakal, Igor Proscurshim, Tony Jiang, Emaryn Mancino, Yacine Salhi, Sammicheli Stefano, Girish Gudi, Andrew Garton, Eric J. Feldman, Andrew Spencer
Publikováno v:
Blood. 140:10182-10184
Autor:
Francesc Bosch, Cecilia Carpio, Yaping Shou, Kate Stumpo, Yujun Wu, Shining Wang, Igor Proscurshim, Harry Miao, Reem Karmali, William Townsend, Swaminathan Iyer, Pier Luigi Zinzani, Jaime Pérez de Oteyza, John A. Radford, Ian Chau, Dima El-Sharkawi, Giuseppe Gritti, Manish R. Patel, Sumit Madan, Silvia Ferrari, Howard A. Burris, Rakesh Popat, Jason B. Kaplan, Leo I. Gordon
Purpose:TAK-659 is an investigational, dual SYK/FLT3 inhibitor with preclinical activity in B-cell malignancy models. This first-in-human, dose-escalation/expansion study aimed to determine the safety, tolerability, MTD/recommended phase II dose (RP2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aaef1b84de76f87afb32ab8593e693f
https://doi.org/10.1158/1078-0432.c.6529245.v1
https://doi.org/10.1158/1078-0432.c.6529245.v1
Autor:
Francesc Bosch, Cecilia Carpio, Yaping Shou, Kate Stumpo, Yujun Wu, Shining Wang, Igor Proscurshim, Harry Miao, Reem Karmali, William Townsend, Swaminathan Iyer, Pier Luigi Zinzani, Jaime Pérez de Oteyza, John A. Radford, Ian Chau, Dima El-Sharkawi, Giuseppe Gritti, Manish R. Patel, Sumit Madan, Silvia Ferrari, Howard A. Burris, Rakesh Popat, Jason B. Kaplan, Leo I. Gordon
SUPPLEMENTARY INFORMATION
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cdd6058b1c7eb3865ab6a158b350545
https://doi.org/10.1158/1078-0432.22475982.v1
https://doi.org/10.1158/1078-0432.22475982.v1
Autor:
Sammicheli Stefano, Camille Grandclement, Valentina Labanca, Stefania De Angelis, Carole Estoppey, Myriam Chimen, Blandine Pouleau, Perrine Suere, Emilie Nallet, Ankita Srivastava, Eric J. Feldman, Igor Proscurshim, Cyril Konto, Eugene Zhukovsky, Mario Perro
Publikováno v:
Blood. 140:6237-6238
Autor:
Sharon Friedlander, Jordi Rodon, Anthony J. Olszanski, Alonzo Martinez, Ulka N. Vaishampayan, Arkadiusz Z. Dudek, Robert Gharavi, John F. Gibbs, Bo Chao, Afshin Dowlati, Christine K. Ward, Bingxia Wang, Alejandro Gomez-Pinillos, Dejan Juric, Vaishali Shinde, Hadeel Assad, Allison Berger, Igor Proscurshim
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A505-A506
BackgroundSUMOylation is a post-translational modification that serves as an important modulator of immune responses via its role in constraining the type I interferon (IFN-1) response. TAK-981 is a small molecule that inhibits SUMOylation and increa
Autor:
Sanjay Goel, Susanna Varkey Ulahannan, Anthony J. Olszanski, Patricia LoRusso, Rachel E. Sanborn, Sunil Sharma, Leisha A. Emens, Matthew Reilley, Victor Priego, Shuli Li, Bingxia Wang, Lixian Dong, Kris Sachsenmeier, John Gibbs, Robert Gharavi, Alonzo Martinez, Igor Proscurshim, Robert J. Fram, Alejandro Gomez-Pinillos, Drew W. Rasco
Publikováno v:
Journal of Clinical Oncology. 40:2506-2506
2506 Background: SUMOylation is a post-translational modification with a role in limiting type 1 interferon (IFN-1)-dependent immune responses. Subasumstat is a small-molecule inhibitor of SUMOylation with the potential to increase antitumor immunity